Your browser doesn't support javascript.
loading
Novel Polyamine-Naphthalene Diimide Conjugates Targeting Histone Deacetylases and DNA for Cancer Phenotype Reprogramming.
Pasini, Alice; Marchetti, Chiara; Sissi, Claudia; Cortesi, Marilisa; Giordano, Emanuele; Minarini, Anna; Milelli, Andrea.
Afiliação
  • Pasini A; Department of Electrical, Electronic and Information Engineering "Guglielmo Marconi" (DEI), Alma Mater Studiorum-University of Bologna, Via Venezia 52, 47521 Cesena (FC), Italy.
  • Marchetti C; Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.
  • Sissi C; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, Italy.
  • Cortesi M; Department of Electrical, Electronic and Information Engineering "Guglielmo Marconi" (DEI), Alma Mater Studiorum-University of Bologna, Via Venezia 52, 47521 Cesena (FC), Italy.
  • Giordano E; Department of Electrical, Electronic and Information Engineering "Guglielmo Marconi" (DEI), Alma Mater Studiorum-University of Bologna, Via Venezia 52, 47521 Cesena (FC), Italy.
  • Minarini A; Health Sciences and Technologies-Interdepartmental Center for Industrial Research (HST-ICIR), Alma Mater Studiorum-University of Bologna, Via Tolara di Sopra 41/E, 40064 Ozzano dell'Emilia (BO), Italy.
  • Milelli A; Advanced Research Center on Electronic Systems (ARCES), Alma Mater Studiorum-University of Bologna, Via Vincenzo Toffano 2/2, 40125 Bologna, Italy.
ACS Med Chem Lett ; 8(12): 1218-1223, 2017 Dec 14.
Article em En | MEDLINE | ID: mdl-29259737
ABSTRACT
A series of hybrid compounds was designed to target histone deacetylases and ds-/G-quadruplex DNAs by merging structural features deriving from Scriptaid and compound 1. Compound 6 binds different DNA arrangements, inhibits HDACs both in vitro and in cells, and is able to induce a reduction of cell proliferation. Moreover, compound 6 displays cell phenotype-reprogramming properties since it prevents the epithelial to mesenchymal transition in cancer cells, inducing a less aggressive and migratory phenotype, which is one of the goals of present innovative strategies in cancer therapies.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália